Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation of Change in Board of Director of the Company.25-04-2023
25-04-2023
Parmax Pharma Ltd - 540359 - Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2023.
Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2023.22-04-2023
Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March, 2023.12-04-2023
Parmax Pharma Ltd - 540359 - Compliance Certificate Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Year Ended On 31St March, 2023.
Compliance Certificate pursuant to Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the year ended on 31st March, 2023.07-04-2023
Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.22-02-2023
Parmax Pharma Ltd - 540359 - Statement Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2022
Statement of Unaudited Financial Results for the quarter and Nine months ended 31st December, 202211-02-2023
Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Outcome Of Board Meeting Of The Company
Statement of Unaudited Financial Results for the quarter and Nine months ended 31st December, 202211-02-2023
Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.08-02-2023
Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2023 ,inter alia, to consider and approve the Meeting of the Board of Directors of Parmax Pharma Limited will be held on Saturday, 11th February, 2023 at 12.30 PM inter alia to consider, approve the Unaudited Financial Results of the quarter and nine months ended 31st December, 2022 and to discuss any other matter with the permission of Board.04-02-2023